Franziska Herster

Franziska Herster

Auto-generated profile, based on publicly available information

Franziska Herster

Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany 1

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
FHFranziska Herster
Franziska Herster
ZBZsofia Bittner
Zsofia Bittner
NANathan Archer
Nathan Archer
SDSabine Dickhöfer
Sabine Dickhöfer
DEDavid Eisel
David Eisel
AWAlexander Weber
Alexander Weber
Psoriasis is an inflammatory skin disease with strong neutrophil (PMN) infiltration and high levels of the antimicrobial peptide, LL37. LL37 in complex with DNA and RNA is thought to initiate disease exacerbation via plasmacytoid dendritic cells. However, the source of nucleic acids supposed to start this initial inflammatory event remains unknown. We show here that primary murine and human PMNs mount a fulminant and self-propagating neutrophil extracellular trap (NET) and cytokine response, but independently of the canonical NET component, DNA. Unexpectedly, RNA, which is abundant in NETs and psoriatic but not healthy skin, in complex with LL37 triggered TLR8/TLR13-mediated cytokine and NET release by PMNs in vitro and in vivo. Transfer of NETs to naive human PMNs prompts additional NET release, promoting further inflammation. Our study thus uncovers a self-propagating vicious cycle contributing to chronic inflammation in psoriasis, and NET-associated RNA (naRNA) as a physiologically relevant NET component.

23 September 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZBZsófia Agnes Bittner
Zsófia Agnes Bittner
XLXiao Liu
Xiao Liu
MTMaria Mateo Tortola
Maria Mateo Tortola
ATANA TAPIA-ABELLAN
ANA TAPIA-ABELLAN
SSSangeetha Shankar
Sangeetha Shankar
AWAlexander Weber
Alexander Weber
Activity of the NLRP3 inflammasome, a critical mediator of inflammation, is controlled by accessory proteins, posttranslational modifications, cellular localization, and oligomerization. How these factors relate is unclear. We show that a well-established drug target, Bruton’s tyrosine kinase (BTK), affects several levels of NLRP3 regulation. BTK directly interacts with NLRP3 in immune cells and phosphorylates four conserved tyrosine residues upon inflammasome activation, in vitro and in vivo. Furthermore, BTK promotes NLRP3 relocalization, oligomerization, ASC polymerization, and full inflammasome assembly, probably by charge neutralization, upon modification of a polybasic linker known to direct NLRP3 Golgi association and inflammasome nucleation. As NLRP3 tyrosine modification by BTK also positively regulates IL-1β release, we propose BTK as a multifunctional positive regulator of NLRP3 regulation and BTK phosphorylation of NLRP3 as a novel and therapeutically tractable step in the control of inflammation.

1 May 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KBKatharina Bitschar
Katharina Bitschar
LSLena Staudenmaier
Lena Staudenmaier
LKLaura Klink
Laura Klink
JFJule Focken
Jule Focken
BSBirgit Sauer
Birgit Sauer
BSBirgit Schittek
Birgit Schittek

1 June 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
FHFranziska Herster
Franziska Herster
SKSusanne Karbach
Susanne Karbach
Madhumita ChatterjeeMadhumita Chatterjee
Madhumita Chatterjee
AWAlexander Weber
Alexander Weber